PMID: 9551757Apr 29, 1998Paper

Nicotine replacement: a new approach to reducing tobacco-related harm

The European Respiratory Journal
C Jiménez-RuizK O Fagerström

Abstract

Primary prevention is usually regarded as the most desirable goal in efforts to control tobacco-related diseases. However, this has not been very effective so far; moreover, it would take 30-40 yrs for primary prevention to translate into major health benefits. Modification of tobacco products and/or reduction of tobacco use may also have some impact on tobacco-related diseases. A tobacco dose-dependent risk has been observed in these diseases, including cancer, cardiovascular diseases, chronic nonspecific respiratory disorders, and problems during pregnancy. Reduced smoking (smoking fewer cigarettes, leading to a reduced intake of toxic substances) may be indicated in individuals who: 1) are failing in cessation attempts; 2) want to quit but are unable to do so; and 3) do not want to quit but want to reduce smoking. Studies have shown that nicotine replacement medications may be an untapped source in efforts to reduce smoking. Based on Austrian data, it is estimated that, approximately 10 yrs after implementation, a 1% reduction in smoking could save 14 male lung cancer deaths each year, and a 50% reduction would save 700 male lives. Inclusion of females and other tobacco-related diseases suggest that thousands of lives could ...Continue Reading

Citations

Feb 20, 2009·Wiener medizinische Wochenschrift·Karl-Heinz MulzerErnest Groman
Jul 29, 2004·Journal of Consulting and Clinical Psychology·Matthew J CarpenterPeter W Callas
Mar 17, 2012·Journal of American College Health : J of ACH·Carla J BergJasjit S Ahluwalia
Jan 5, 2002·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·K O Fagerström
Dec 1, 2012·Health Education Research·E A PinskerJ S Ahluwalia
Mar 3, 2010·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Carla J BergJasjit S Ahluwalia
Aug 22, 2013·Journal of Clinical Psychopharmacology·Peter SelbyUsoa E Busto
Sep 30, 2005·Journal of General Internal Medicine·Michael D SteinBradley J Anderson
Mar 19, 2005·Journal of Addictive Diseases·Anthony J AlbergKathy J Helzlsouer
Oct 19, 2001·Clinical Pharmacokinetics·N G SchneiderE Lunell
Jan 20, 2004·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Anne M Joseph, Steven S Fu
Sep 27, 2014·Journal of Smoking Cessation·Carla J Berg
Dec 7, 2007·Archivos de bronconeumología·Isabel NerínAdriana Marqueta
Mar 11, 2008·La Revue de médecine interne·L HarcouëtL Guillevin
Feb 20, 2007·Addictive Behaviors·Kolawole S OkuyemiJasjit S Ahluwalia
Apr 17, 2015·American Journal of Public Health·Jamie GuilloryPamela M Ling
May 10, 2012·Journal of Environmental and Public Health·Carla J Berg, Gillian L Schauer
Apr 7, 2016·Tobacco Control·Jamie GuilloryPamela M Ling
Feb 7, 2009·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Janet L ThomasJasjit S Ahluwalia

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.